2012
DOI: 10.1016/j.ajhg.2011.11.021
|View full text |Cite
|
Sign up to set email alerts
|

Deletion of KDM6A, a Histone Demethylase Interacting with MLL2, in Three Patients with Kabuki Syndrome

Abstract: Kabuki syndrome (KS) is a rare genetic disease that causes developmental delay and congenital anomalies. Since the identification of MLL2 mutations as the primary cause of KS, such mutations have been identified in 56%-76% of affected individuals, suggesting that there may be additional genes associated with KS. Here, we describe three KS individuals with de novo partial or complete deletions of an X chromosome gene, KDM6A, that encodes a histone demethylase that interacts with MLL2. Although KDM6A escapes X i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

9
309
1
8

Year Published

2012
2012
2020
2020

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 339 publications
(340 citation statements)
references
References 36 publications
(59 reference statements)
9
309
1
8
Order By: Relevance
“…CHD7 is a transcriptional cofactor of SOX2, regulating target genes like JAG1 (Alagille syndrome), Mycn (Feingold syndrome), and Gli3 (Pallister-Hall syndrome) phenotypes observed for CHARGE syndrome. The genes which are mutated in Kabuki syndrome are KMT2D, a histone H3 lysine 4 (H3K4) methyltransferase (Li et al, 2011;Ng et al, 2010), and KDM6A, a lysine-specific histone demethylase, that interacts with KMT2D (Lederer et al, 2012). KMT2D is required for setting the active mark, H3K4 di-and trimethylation, while KDM6A removes the repressive mark, H3K27 trimethylation.…”
Section: Chd7 Protein Complexes and Their Function In Development Amentioning
confidence: 99%
“…CHD7 is a transcriptional cofactor of SOX2, regulating target genes like JAG1 (Alagille syndrome), Mycn (Feingold syndrome), and Gli3 (Pallister-Hall syndrome) phenotypes observed for CHARGE syndrome. The genes which are mutated in Kabuki syndrome are KMT2D, a histone H3 lysine 4 (H3K4) methyltransferase (Li et al, 2011;Ng et al, 2010), and KDM6A, a lysine-specific histone demethylase, that interacts with KMT2D (Lederer et al, 2012). KMT2D is required for setting the active mark, H3K4 di-and trimethylation, while KDM6A removes the repressive mark, H3K27 trimethylation.…”
Section: Chd7 Protein Complexes and Their Function In Development Amentioning
confidence: 99%
“…In light of recent findings, however, pre-existing data pertaining to the significance of the X chromosome in this etiology may indeed still be of great relevance. The recent identification of the MLL2 gene believed to be implicative in KS, 3 and the more recently proposed X chromosomal interactions with this gene in a small subset of patients 24 have shed light on this ambiguity, and revealed the search into more complexed genomic interactions as a plausible line for further investigation.…”
Section: Early Researchmentioning
confidence: 99%
“…Lederer et al 24 most recently published findings on data from two female and one male patient with KS. De novo partial or complete deletions of an X chromosome gene, KDM6A (lysine (K)-specific demethylase 6A, also known as UTX) were identified in all three patients.…”
Section: The Mll2 Gene Associationmentioning
confidence: 99%
“…6,8,10 Mais recentemente, um grupo de pesquisa belga descobriu o envolvimento do gene KDM6A num pequeno grupo sem mutação no MLL2. 11 Esse gene regula a atividade genética de MLL2 nos processos de controle epigenéticos e pode ser resposável por casos de SK mesmo na ausência de mutações no MLL2.…”
Section: Introductionunclassified